It was a newsy week for Wisconsin’s innovation community. Catch up on some of the major happenings with these recent headlines:
May Mobility, the autonomous vehicle startup based in Ann Arbor, MI, had an action-packed 2017.
Karen DeSalvo has experience working in the public sector, but she’s hardly what you’d call a government bureaucrat.
DeSalvo, who is trained as a physician, served as the National Coordinator for Health Information Technology from 2014 to 2016 under President Barack... Read more »
Many drugs for inflammatory and autoimmune disorders work by suppressing the immune system, an approach that puts patients at risk of infection among other side effects. Pandion Therapeutics is developing antibody drugs that it says could instead work with the immune... Read more »
Madison, WI-based Nordic said its acquisition of Chicago-based Claro’s revenue cycle... Read more »
Technology took center stage this week as the nation’s retailers made their annual pilgrimage to New York.
At the National Retail Federation’s three-day conference, which ended Tuesday, the discussion centered on both the disruptive effects and potential promise of e-commerce technologies.... Read more »
Titan Spine, a Mequon, WI-based company that sells surgical implants designed for spinal surgeons to use when operating on patients, raised more than $7.8 million from investors across two separate funding rounds that closed in late December.
Titan’s products include a... Read more »
Rounding out our series of perspectives and prognostications for the new year, we asked people in Xconomy’s network about trust in the tech industry.
Specifically, if you think public perception about the tech industry took a turn for the worse... Read more »
San Antonio—Evestra, a San Antonio life science company that develops women’s health products, has a new shareholder: pharmaceutical firm Gedeon Richter, a long-time partner based in Budapest, Hungary.
Gedeon, which recorded revenue of 1.25 billion euro ($1.32 billion) in 2016,... Read more »
This morning has brought another positive development in the rapidly changing treatment landscape for lung cancer. Merck reported that a combination regimen utilizing its immunotherapy drug, pembrolizumab (Keytruda), has succeeded in a confirmational Phase 3 study.
True Fit, a Boston-area startup that is creating “a genome for apparel and footwear,” announced this morning a Series C investment of $55 million.
Georgian Partners led the funding round with participation from existing investors Jump Capital, Signal Peak Ventures, and... Read more »
Boston’s healthcare technology cluster is getting more crowded. Dutch healthtech giant Philips intends to plant an even bigger flag here, ramping up its local efforts to develop products like machine-learning software for healthcare, as other big firms like IBM and General... Read more »